UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009634 |
|---|---|
| Receipt number | R000010813 |
| Scientific Title | Phase II/III study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemotherapy for resectable pancreatic cancer (Prep-02/JSAP-05) |
| Date of disclosure of the study information | 2012/12/26 |
| Last modified on | 2019/07/04 09:22:36 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/12/26 13:57:29 | ||
| 2 | Update | 2012/12/26 15:46:39 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 3 | Update | 2013/01/05 17:02:50 | Recruitment status |
|
| 4 | Update | 2013/12/26 09:19:15 | TEL Homepage URL |
|
| 5 | Update | 2014/06/26 12:12:31 | Email1 |
|
| 6 | Update | 2014/07/28 12:11:03 | Email1 |
|
| 7 | Update | 2016/06/27 12:16:04 | Recruitment status |
|
| 8 | Update | 2017/12/19 13:45:14 | Homepage URL Name of primary person or sponsor Organization Category of Funding Organization |
|
| 9 | Update | 2017/12/19 13:47:15 | Last follow-up date |
|
| 10 | Update | 2019/07/02 09:38:04 | Recruitment status Date of IRB |
|
| 11 | Update | 2019/07/04 09:18:49 | Publication of results URL related to results and publications Number of participants that the trial has enrolled |
|
| 12 | Update | 2019/07/04 09:22:36 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Organization Organization Division name Division name Zip code Organization Organization Division name Division name Organization Organization Address Address Tel |
